CASI Pharmaceuticals, Inc.·4

May 26, 4:13 PM ET

Wu Yue Alexander 4

4 · CASI Pharmaceuticals, Inc. · Filed May 26, 2022

Insider Transaction Report

Form 4
Period: 2022-05-25
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-05-25+388,387388,387 total
    Exercise: $0.47Exp: 2032-05-25Common Stock (388,387 underlying)
Footnotes (1)
  • [F1]Stock option award will vest ratably quarterly to the end of the year.

Documents

2 files